NCT02046486View on ClinicalTrials.gov

OraL Crushed and dIspersed Ticagrelor 180mg Compared to Whole Tablets of eQUal Dose in STEMI Patients unDergoing Primary PCI: a Pharmacokinetic/Pharmacodynamic Study (the LIQUID Study)

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions

ST Elevation Myocardial Infarction

Interventions

DRUG

Ticagrelor 180mg whole tablets

DRUG

Ticagrelor 180mg crushed and dispersed

Trial Locations (1)

26500

Patras University Hospital Department of Cardiology, Pátrai

All Listed Sponsors

lead

University of Patras

OTHER

NCT02046486 - OraL Crushed and dIspersed Ticagrelor 180mg Compared to Whole Tablets of eQUal Dose in STEMI Patients unDergoing Primary PCI: a Pharmacokinetic/Pharmacodynamic Study (the LIQUID Study) | Biotech Hunter | Biotech Hunter